ATE331784T1 - Verfahren zur diagnose von fettsucht - Google Patents
Verfahren zur diagnose von fettsuchtInfo
- Publication number
- ATE331784T1 ATE331784T1 AT02293085T AT02293085T ATE331784T1 AT E331784 T1 ATE331784 T1 AT E331784T1 AT 02293085 T AT02293085 T AT 02293085T AT 02293085 T AT02293085 T AT 02293085T AT E331784 T1 ATE331784 T1 AT E331784T1
- Authority
- AT
- Austria
- Prior art keywords
- obesity
- diagnosis
- polymorphisms
- therapy
- identification
- Prior art date
Links
- 208000008589 Obesity Diseases 0.000 title abstract 3
- 238000003745 diagnosis Methods 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 235000020824 obesity Nutrition 0.000 title abstract 2
- 208000012696 congenital leptin deficiency Diseases 0.000 abstract 1
- 208000001022 morbid obesity Diseases 0.000 abstract 1
- 102000054765 polymorphisms of proteins Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/07—Animals genetically altered by homologous recombination
- A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/172—Haplotypes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/04—Endocrine or metabolic disorders
- G01N2800/044—Hyperlipemia or hypolipemia, e.g. dyslipidaemia, obesity
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physics & Mathematics (AREA)
- Urology & Nephrology (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Pathology (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Biophysics (AREA)
- Diabetes (AREA)
- General Engineering & Computer Science (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Endocrinology (AREA)
- Child & Adolescent Psychology (AREA)
- Obesity (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02293085A EP1428875B1 (de) | 2002-12-13 | 2002-12-13 | Verfahren zur Diagnose von Fettsucht |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE331784T1 true ATE331784T1 (de) | 2006-07-15 |
Family
ID=32319694
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02293085T ATE331784T1 (de) | 2002-12-13 | 2002-12-13 | Verfahren zur diagnose von fettsucht |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20060269919A1 (de) |
| EP (2) | EP1428875B1 (de) |
| JP (1) | JP2006509519A (de) |
| AT (1) | ATE331784T1 (de) |
| AU (1) | AU2003276616A1 (de) |
| CA (1) | CA2509831A1 (de) |
| DE (1) | DE60212861T2 (de) |
| ES (1) | ES2266432T3 (de) |
| WO (1) | WO2004055180A1 (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2087789A1 (de) | 2008-02-06 | 2009-08-12 | Heinrich-Heine-Universität Düsseldorf | FTO-modifiziertes nichtmenschliches Säugetier |
| US8877443B2 (en) | 2009-05-15 | 2014-11-04 | The University Of Tokyo | Method and kit for evaluation of predisposition to development of obesity, anti-obesity agent and method for screening thereof, non-human animal, adipose tissue, adipocyte, method for production of transgenic mouse, antigen, and antibody |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998037224A1 (en) * | 1997-02-25 | 1998-08-27 | Genzyme Transgenics Corporation | Transgenically produced non-secreted proteins |
| ES2317710T3 (es) * | 1998-11-05 | 2009-04-16 | Thomas Jefferson University | Tratamiento de la enfermedad de parkinson con oligonucleotidos. |
| JP4219617B2 (ja) * | 2001-06-15 | 2009-02-04 | 独立行政法人科学技術振興機構 | グリーン蛍光タンパク質遺伝子により形質転換されたトランスジェニック動物 |
-
2002
- 2002-12-13 AT AT02293085T patent/ATE331784T1/de not_active IP Right Cessation
- 2002-12-13 DE DE60212861T patent/DE60212861T2/de not_active Expired - Lifetime
- 2002-12-13 EP EP02293085A patent/EP1428875B1/de not_active Expired - Lifetime
- 2002-12-13 ES ES02293085T patent/ES2266432T3/es not_active Expired - Lifetime
-
2003
- 2003-10-31 WO PCT/IB2003/005282 patent/WO2004055180A1/en active Application Filing
- 2003-10-31 EP EP03813219A patent/EP1572999A1/de not_active Withdrawn
- 2003-10-31 US US10/538,922 patent/US20060269919A1/en not_active Abandoned
- 2003-10-31 CA CA002509831A patent/CA2509831A1/en not_active Abandoned
- 2003-10-31 AU AU2003276616A patent/AU2003276616A1/en not_active Abandoned
- 2003-10-31 JP JP2004559999A patent/JP2006509519A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2003276616A1 (en) | 2004-07-09 |
| WO2004055180A1 (en) | 2004-07-01 |
| CA2509831A1 (en) | 2004-07-01 |
| DE60212861D1 (de) | 2006-08-10 |
| EP1572999A1 (de) | 2005-09-14 |
| EP1428875A1 (de) | 2004-06-16 |
| ES2266432T3 (es) | 2007-03-01 |
| DE60212861T2 (de) | 2007-03-01 |
| JP2006509519A (ja) | 2006-03-23 |
| US20060269919A1 (en) | 2006-11-30 |
| EP1428875B1 (de) | 2006-06-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60035163D1 (de) | Abc1 polypeptide und verfahren und reagenzien zur modulation des cholesterolgehalts | |
| IN2015KN00290A (de) | ||
| ATE474847T1 (de) | Verfahren zur herstellung von dipeptiden | |
| ATE478944T1 (de) | Zytokin ligand zur behandlung von asthma und atemwegsüberreaktivität | |
| ATE435012T1 (de) | Verfahren zur behandlung von parkinson-krankheit | |
| BRPI0407207A (pt) | Método para tratar, prevenir e diagnosticar uma infecção por heliocobacter | |
| ATE415175T1 (de) | Ace2-aktivierung zur behandlung von herz, lungen, und nierenkrankheit und bluthochdruck | |
| WO2003007803A3 (en) | Methods for diagnosing and treating alzheimer's disease and parkinson's disease | |
| DE60028544D1 (de) | Prostata-spezifische gene zur diagnose, prognose und behandlung von prostata-krebs | |
| DE60323994D1 (de) | Verfahren zur herstellung von 2-chlor-1,1,1,2,3,3,3-heptafluorpropan, hexafluorpropen und 1,1,1,2,3,3,3-heptafluorpropan | |
| ATE426043T1 (de) | Verfahren zur identifizierung des brustkrebsrisikos | |
| DE60331111D1 (de) | Verfahren zur Herstellung von martensitaushärtendem Stahl | |
| ATE356995T1 (de) | Verfahren zur identifizierung von mitteln zur behandlung von diabetes | |
| DE60209541D1 (de) | Verfahren zur herstellung von sekundären und tertiären aminofunktionellensilanen, iminoorganosilanen und/oder imidoorganosilanen | |
| WO2005027710A3 (en) | Methods for identifying subjects at risk of melanoma and treatments thereof | |
| ATE400560T1 (de) | Verfahren zur herstellung von 10,11 dihydro 10 hydroxy 5h-dibenz/b,f/azepin-5-carbonsäureamid und 10,11 dihydro 10 oxo-5h-dibenz/b,f/azepin-5 carbonsäureamid | |
| ATE402684T1 (de) | Elastische befestigungslasche, befestigungssystem und verfahren zur herstellung davon | |
| GB0228337D0 (en) | Replication protein | |
| DE60212861D1 (de) | Verfahren zur Diagnose von Fettsucht | |
| DE60324272D1 (de) | Verfahren zum kühlen von stahlblech und verfahren zur herstellung von stahlblech | |
| ATE360425T1 (de) | Verwendung von quetiapin für die behandlung von kokain-abhängigkeit | |
| AU2003280929A1 (en) | A baldness related gene and the polypeptide encoded thereby, and uses thereof | |
| DE602004030107D1 (de) | Suszeptibilitätsgen für die alzheimersche krankheit | |
| DE60212930D1 (de) | Detektionsmethode für Zielmoleküle, Reagenz sowie Verfahren zur Detektion von SNPs in DNA Nukleotidsequenzen | |
| DE602004022702D1 (de) | Verfahren und kit zur abschätzung der nebenwirkung durch eine paclitaxel-therapie |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |